KRAS and breast carcinoma: Thus, the finding of heightened expression of HIF1α and HIF target genes in patients’ breast cancers with amplified KRAS can now be directly related to a perturbation of KRAS activity and likely that of more commonly mutated downstream elements in the KRAS pathway.